ClinConnect ClinConnect Logo
Search / Trial NCT06909890

A Study of Chios Mastic Water in Dyspepsia

Launched by HAROKOPIO UNIVERSITY · Mar 27, 2025

Trial Information

Current as of June 27, 2025

Not yet recruiting

Keywords

Pistacia Lentiscus Var. Chia Chios Mastic Dyspepsia Gastrointestinal Health

ClinConnect Summary

This clinical trial is studying the effects of Chios mastic water, a natural product known for its health benefits, on people with dyspepsia, which is a term for digestive discomfort. The goal is to see if drinking a carbonated beverage enriched with Chios mastic water can help improve symptoms like stomach pain or bloating. The study will last for three months and will involve adults aged 30 to 60 who have a healthy body weight and experience dyspepsia.

Participants will be randomly placed into two groups: one will drink the mastic water beverage daily, while the other will receive a similar-looking drink that doesn't have any active ingredients. Throughout the study, researchers will check how participants are feeling, their quality of life, and other health indicators before and after the trial. It's important to note that individuals with certain chronic health conditions, those taking specific medications, or those who are pregnant or breastfeeding will not be eligible to participate. This trial is currently not recruiting participants yet, but it offers a unique opportunity to explore a natural approach to managing digestive issues.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age 30-60 years old.
  • Body mass index of 20-35 kg/m2.
  • Presence of dyspepsia.
  • Exclusion Criteria:
  • Presence of chronic diseases (e.g. diabetes mellitus, cancer, cardiovascular, hepatic, renal, respiratory, chronic inflammatory and psychiatric diseases).
  • Presence of other chronic gastrointestinal diseases (e.g. gastroesophageal reflux, inflammatory bowel disease and celiac disease).
  • Use of immunosuppressants, anti-inflammatories, antibiotics and corticosteroids.
  • Use of dietary supplements or other products with Chios mastic.
  • Excessive alcohol consumption (\>210 g and \>140 g of ethanol per week for men and women, respectively).
  • Currently on a weight-loss diet or recent (within 6 months) significant change in lifestyle habits.
  • Pregnancy or breast feeding (for women)

About Harokopio University

Harokopio University, located in Athens, Greece, is a prominent academic institution dedicated to advancing research and education in various fields, including health sciences and nutrition. With a strong commitment to interdisciplinary collaboration, the university actively engages in clinical trials aimed at exploring innovative solutions to pressing health challenges. Through its rigorous research programs and partnerships with healthcare professionals, Harokopio University strives to contribute valuable insights to the scientific community and improve public health outcomes.

Locations

Kallithea, Attica, Greece

Patients applied

0 patients applied

Trial Officials

Giannis Arnaoutis, PhD

Principal Investigator

Department of Nutrition and Dietetics, School of Health Sciences and Education, Harokopio University of Athens

Labros Sidossis, PhD

Study Director

Department of Nutrition and Dietetics, School of Health Sciences and Education, Harokopio University of Athens

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported